Reynders McVeigh Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-65,490
| Closed | -$269K | – | 237 |
|
|
2022
Q1 | $269K | Hold |
65,490
| – | – | 0.02% | 204 |
|
|
2021
Q4 | $234K | Sell |
65,490
-169,000
| -72% | -$604K | 0.01% | 217 |
|
|
2021
Q3 | $854K | Sell |
234,490
-25,000
| -10% | -$91K | 0.05% | 117 |
|
|
2021
Q2 | $1.13M | Sell |
259,490
-100,510
| -28% | -$438K | 0.07% | 102 |
|
|
2021
Q1 | $1.48M | Buy |
360,000
+106,068
| +42% | +$436K | 0.1% | 92 |
|
|
2020
Q4 | $1.01M | Buy |
+253,932
| New | +$1.01M | 0.07% | 100 |
|